AVITA Medical, Inc. (RCEL)
16.59
+0.91
(+5.80%)
USD |
NASDAQ |
Nov 06, 16:00
16.60
+0.01
(+0.06%)
After-Hours: 20:00
AVITA Medical Total Long Term Debt (Quarterly) : 47.13M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 47.13M |
| June 30, 2026 | 48.48M |
| March 31, 2026 | 48.12M |
| December 31, 2025 | 45.12M |
| September 30, 2025 | 44.77M |
| June 30, 2025 | 44.59M |
| March 31, 2025 | 44.07M |
| December 31, 2024 | 45.08M |
| September 30, 2024 | 45.63M |
| June 30, 2024 | 44.27M |
| March 31, 2024 | 43.83M |
| December 31, 2023 | 41.51M |
| Date | Value |
|---|---|
| September 30, 2023 | 1.845M |
| June 30, 2023 | 1.047M |
| March 31, 2023 | 1.235M |
| December 31, 2022 | 0.306M |
| September 30, 2022 | 0.405M |
| June 30, 2022 | 0.532M |
| March 31, 2022 | 0.726M |
| June 30, 2021 | 0.878M |
| March 31, 2021 | 1.06M |
| December 31, 2020 | 1.241M |
| September 30, 2020 | 1.783M |
| June 30, 2020 | 1.928M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 42.77M |
| Halozyme Therapeutics, Inc. | 3.250B |
| Agenus, Inc. | 271.09M |
| Amgen, Inc. | 54.01B |
| Fate Therapeutics, Inc. | 69.38M |